SNAPPER: Prospective Evaluation of Renal effects
We are inviting you to take part in this sub study because you have joined the SNAP platform, and you have a risk factor for developing injury to your kidneys.
This sub-study is being conducted in Australia.
Lead Investigator: Amy Legg - Brisbane Women's Hospital, Menzies School of Health
Email: amytherese.legg@menzies.edu.au
Please read the below information to learn more about the assessments and tests involved in this sub-study.
We will also be using results from your blood tests that are already being done by the hospital. We will not take any additional blood tests from you.
Risks:
Benefits:
You can withdraw from the sub study and/or from future use of your samples at any time, just notify a member of the SNAP study team.
If you withdraw, we will keep any information we have collected about you up until you withdraw. If you do not agree with this, you should not join this substudy.
SNAP Trial
SNAPstrat: Patient stratification using SAB sub-phenotypes
Cefazolin Versus Penicillin for Penicillin-Susceptible Staphylococcus aureus Bacteremia: A Secondary Analysis of the SNAP Backbone Trials
Significance of S. aureus bacteriuria in patients hospitalized with S. aureus bacteremia
A statistical genomics framework to improve prediction of treatment outcomes of Staphylococcus aureus bacteraemia (SAB)